Improving outcomes for Australian patients and families with bone marrow failure related diseases through comprehensive clinicogenomic care and collaborative research.
2021-2024 (Fellowship): Improving outcomes for Australian patients and families with bone marrow failure related diseases through comprehensive clinicogenomic care and collaborative research. Dr Lucy Fox, Peter MacCallum Cancer Centre.
Dr Lucy Fox is the Bone Marrow Failure Fellow at the Victorian Comprehensive Cancer Centre and the Clinical Research Fellow at the Aplastic Anaemia Registry (AAR). Her research focus is both inherited and acquired Bone Marrow Failure Syndromes, including the genetic changes that occur in both of these conditions. She is the recipient of the Doctoral Degree Scholarship, and has completed her Doctor of Medical Science at the University of Melbourne.
This fellowship will support provision of expert genomic diagnostic testing and clinical care to patients with Bone Marrow Failure Syndromes. It will also support ongoing enrolment of patients to the Aplastic Anaemia and Other Bone Marrow Failure Syndromes Registry (AAR), Australian Marrow Failure Biobank, and facilitate clinical trial opportunities for Australian patients.
Related Projects
Functional interrogation of Loci associated with the regulation of haematopoiesis
2019-2021 (Fellowship): The Alex Gadomski Fellowship. Functional interrogation of Loci associated with the regulation of haematopoiesis. Dr Kirsten Fairfax, Menzies Institute for Medical Research and University of Tasmania. To understand bone ...
Read moreA preclinical trial of next generation gene editing for the prevention of bone marrow failure in Fanconi Anaemia
2023- 2025 (Fellowship): The inaugural Captain Courageous Fellowship. A preclinical trial of next generation gene editing for the prevention of bone marrow failure in Fanconi Anaemia. Dr Astrid Glaser at the Genome Stability Unit of St Vincent’s ...
Read moreDissecting immune dysregulation in acquired bone marrow failure syndromes to identify new therapeutic leads.
2022-2025 (Fellowship): Dissecting immune dysregulation in acquired Bone Marrow Failure Syndromes to identify new therapeutic leads. Associate Professor Rachel Koldej, ACRF Translational Research Laboratory, Melbourne Health. Bone Marrow Failure ...
Read moreModelling consequences of cell abundance, heterogeneity and origin for autologous cell therapy in genetic Bone Marrow Failure Syndromes.
2020-2023 (Fellowship): Modelling consequences of cell abundance, heterogeneity and origin for autologous cell therapy in genetic Bone Marrow Failure Syndromes. Dr Parvathy Venugopal, Centre for Cancer Biology / University of South Australia. In ...
Read more